Clinical trials of a potential coronavirus vaccine developed by China's Sinovac has got the go-ahead in Brazil.
Trials will be conducted by 12 research centres in Sao Paulo, Rio de Janeiro, Minas Gerais, Brasilia, Rio Grande do Sul and Parana.
According to Brazilian health regulator Anvisa, the agreement with Sinovac will also look at the transference of technology to produce the potential vaccine locally.
It comes as the country surpassed 1.5 million confirmed cases of COVID-19, with the death toll at 63,174.


Trump says historic summit with Xi, Putin already a 'win' before event
Saudi coalition reports damage after Houthi missile threat towards Riyadh
More than 47,000 evacuated in India ahead of Cyclone Akvan
Israel launches ground operation in central Gaza
Xi, Putin blast Western 'protectionism', sanctions as Trump lands in China